Found: 4
Select item for more details and to access through your institution.
Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 12, p. 1871, doi. 10.1002/eji.202048712
- By:
- Publication type:
- Article
Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32485-9
- By:
- Publication type:
- Article
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32485-9
- By:
- Publication type:
- Article